Text size: S M L XL

Related Research

Addiction Impacts on Women and Aboriginal People
Given previous experiences in our context there are two major sub-groups of special interests within the SALOME study target population - women and Aboriginal people - each likely representing a third of the participants.

Different gender and cultural patterns and their underlying mechanisms have tremendous implications for the provision of care for those struggling with drugs. Therefore, it is crucial to understand how the treatment provided in the SALOME trial impacts women and Aboriginal people, in order to better reach and treat these sub-populations.

Dr. Oviedo-Joekes has received funding from CIHR and the Institute of Gender and Health, to further explore this. More information on this study will be posted soon.

Results Show that North America’s First Heroin Therapy Study
Keeps Patients in Treatment, Improves Their Health and Reduces
Illegal Activity

Published in the August 20th, 2009 issue of the New England Journal of Medicine (NEJM), results of North America’s first heroin-assisted treatment study (North American Opiate Medication Initiative - NAOMI Study) confirm again that supervised prescribed heroin is a safe and effective treatment for people with chronic heroin addiction who have not benefited from previous treatments.

For more information, please click here.

More information on NAOMI can be found here

Injectable Hydromorphone Versus Diacetylmorphine for the Treatment of Opioid Dependence: A Pilot Study
Using data from the North American Opioid Maintenance Initiative study, a Phase III randomized and parallel arm trial, this pilot study was aimed at testing if treatment response with injectable hydromorphone differs compared to diacetylmorphine in the treatment of long-term opioid addiction.

For more information, please click here.